Last checked at 6 Apr 2009 09:35
RNS Number : 1804Q
Alliance Pharma PLC
06 April 2009
| For immediate release | 6 April 2009 |
ALLIANCE PHARMA PLC
("Alliance" or "the Company")
Directorate Change
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that Dr Mark Tomlinson, the Company's Medical Director, has informed the Board of his intention to leave Alliance in July 2009 to pursue another opportunity.
Michael Gatenby, Alliance Pharma's Chairman, said: "On behalf of the Board I would like to thank Mark for his contribution to the Company and wish him well for the future."
For further information:
| Alliance Pharma plc | + 44 (0) 1249 466966 |
| John Dawson, Chief Executive | |
| Richard Wright, Finance Director | |
| www.alliancepharma.co.uk | |
| | |
| Buchanan Communications | + 44 (0) 20 7466 5000 |
| Mark Court / Rebecca Skye Dietrich / Stasa Filiplic | |
| | |
| Numis Securities Limited | + 44 (0) 20 7260 1000 |
| Nominated Adviser: Michael Meade / Brent Nabbs | |
| Corporate Broking: David Poutney | |
This information is provided by RNS
The company news service from the London Stock Exchange